SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Miguel Valle, Rosario Martos, María Dolores Cañete, Rosario Valle, Eva L van Donkelaar, Francisco Bermudo, Ramón Cañete, Association of serum uric acid levels to inflammation biomarkers and endothelial dysfunction in obese prepubertal children, Pediatric Diabetes, 2015, 16, 1
  2. 2
    Ming-Ling Chang, Chen-Ming Hsu, Jeng-Hwei Tseng, Yung-Kuan Tsou, Shu-Chun Chen, Shuen-Shian Shiau, Chau-Ting Yeh, Cheng-Tang Chiu, Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders, Journal of Gastroenterology and Hepatology, 2015, 30, 2
  3. 3
    Muhammad Khan, Frank Joseph, Adipose Tissue and Adipokines: The Association with and Application of Adipokines in Obesity, Scientifica, 2014, 2014, 1

    CrossRef

  4. 4
    Ashok Kumar Ahirwar, Anju Jain, Binita Goswami, M.K. Bhatnagar, Jayashree Bhatacharjee, Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2014, 8, 3, 152

    CrossRef

  5. 5
    Eunjung Kim, Eun Jung Kim, Seung-Won Seo, Cheol-Goo Hur, Robin A McGregor, Myung-Sook Choi, Meta-Review of Protein Network Regulating Obesity Between Validated Obesity Candidate Genes in the White Adipose Tissue of High-Fat Diet-Induced Obese C57BL/6J Mice, Critical Reviews in Food Science and Nutrition, 2014, 54, 7, 910

    CrossRef

  6. 6
    Un Jung, Myung-Sook Choi, Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease, International Journal of Molecular Sciences, 2014, 15, 4, 6184

    CrossRef

  7. 7
    Yoshito Ikeda, Hiroyuki Tsuchiya, Susumu Hama, Kazuaki Kajimoto, Kentaro Kogure, Resistin regulates the expression of plasminogen activator inhibitor-1 in 3T3-L1 adipocytes, Biochemical and Biophysical Research Communications, 2014, 448, 2, 129

    CrossRef

  8. 8
    Michael Safaee, Matthew Z. Sun, Taemin Oh, Manish K. Aghi, Mitchel S. Berger, Michael W. McDermott, Andrew T. Parsa, Orin Bloch, Use of thrombin-based hemostatic matrix during meningioma resection: A potential risk factor for perioperative thromboembolic events, Clinical Neurology and Neurosurgery, 2014, 119, 116

    CrossRef

  9. 9
    Mark M. Smits, Pier Woudstra, Kristina M. Utzschneider, Jenny Tong, Fernando Gerchman, Mirjam Faulenbach, Darcy B. Carr, Kathryn Aston-Mourney, Alan Chait, Robert H. Knopp, James B. Meigs, Edward J. Boyko, Steven E. Kahn, Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis, Annals of Epidemiology, 2013, 23, 7, 415

    CrossRef

  10. 10
    Kyoung Sik Park, Aucubin, a naturally occurring iridoid glycoside inhibits TNF-α-induced inflammatory responses through suppression of NF-κB activation in 3T3-L1 adipocytes, Cytokine, 2013, 62, 3, 407

    CrossRef

  11. 11
    Ihosvany Fernández-Bello, Francisco J López-Longo, Elena G Arias-Salgado, Víctor Jiménez-Yuste, Nora V Butta, Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity, Orphanet Journal of Rare Diseases, 2013, 8, 1, 81

    CrossRef

  12. 12
    C. C. Lee, C. Lorenzo, S. M. Haffner, L. E. Wagenknecht, A. Festa, M. O. Goodarzi, D. Stefanovski, N. C. Olson, J. M. Norris, M. J. Rewers, A. J. Hanley, The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS), Diabetologia, 2013, 56, 1, 112

    CrossRef

  13. 13
    Elena Valassi, Beverly M.K. Biller, Anne Klibanski, Madhusmita Misra, Adipokines and Cardiovascular Risk in Cushing’s Syndrome, Neuroendocrinology, 2012, 95, 3, 187

    CrossRef

  14. 14
    Carlos Ewerton Maia Rodrigues, Eloisa Bonfá, Maria Teresa Correia Caleiro, Margarete B. Vendramini, Cleonice Bueno, Jaqueline B. Lopes, Jozélio Freire de Carvalho, Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome, Arthritis Care & Research, 2012, 64, 10
  15. 15
    Vanessa L. Williams, Rachel E. Martin, John L. Franklin, Robert W. Hardy, Joseph L. Messina, Injury-induced insulin resistance in adipose tissue, Biochemical and Biophysical Research Communications, 2012, 421, 3, 442

    CrossRef

  16. 16
    Zaid Al-Hamodi, Ikram S Ismail, Riyadh Saif-Ali, Khaled A Ahmed, Sekaran Muniandy, Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects, Cardiovascular Diabetology, 2011, 10, 1, 23

    CrossRef

  17. 17
    Paul D. Stein, Fadi Matta, Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism, Critical Care Clinics, 2011, 27, 4, 907

    CrossRef

  18. 18
    Jonas Andersson, Henrik Almroth, Niklas Höglund, Steen Jensen, Per Tornvall, Anders Englund, Mårten Rosenqvist, Kurt Boman, Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion, Thrombosis Research, 2011, 127, 3, 189

    CrossRef

  19. 19
    Paul D. Stein, Fadi Matta, Jose Goldman, Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox, Thrombosis Research, 2011, 128, 6, 518

    CrossRef

  20. 20
    Zhao-min Liu, Suzanne C. Ho, The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes, Maturitas, 2011, 70, 2, 176

    CrossRef

  21. 21
    R. Swiatkowska-Stodulska, S. Kaniuka-Jakubowska, P. Wisniewski, A. Skibowska-Bielinska, K. Sworczak, The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing's syndrome, European Journal of Endocrinology, 2011, 165, 6, 865

    CrossRef

  22. 22
    Ludek Slavik, Jana Prochazkova, Martin Prochazka, Ondrej Simetka, Antonin Hlusi, Jana Ulehlova, The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers, Biomedical Papers, 2011, 155, 4, 333

    CrossRef

  23. 23
    Peter Chudý, Daniela Kotuličová, Ján Staško, Peter Kubisz, The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria, Blood Coagulation & Fibrinolysis, 2011, 22, 6, 493

    CrossRef

  24. 24
    M. Odette Gore, Silvio E. Inzucchi, Darren K. McGuire, Preventive Cardiology: Companion to Braunwald's Heart Disease, 2011,

    CrossRef

  25. 25
    Aletta Elisabeth Schutte, Hugo Willem Huisman, Rudolph Schutte, Johannes Marthinus van Rooyen, Leoné Malan, Catharina Maria Theresia Fourie, Nicolaas Theodore Malan, Adipokines and cardiometabolic function: How are they interlinked?, Regulatory Peptides, 2010, 164, 2-3, 133

    CrossRef

  26. 26
    Paul D. Stein, Fadi Matta, Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism, Clinics in Chest Medicine, 2010, 31, 4, 611

    CrossRef

  27. 27
    Varut Lohsiriwat, Watchara Pongsanguansuk, Narong Lertakyamanee, Darin Lohsiriwat, Impact of Metabolic Syndrome on the Short-Term Outcomes of Colorectal Cancer Surgery, Diseases of the Colon & Rectum, 2010, 53, 2, 186

    CrossRef

  28. 28
    Ana Lucia de Almeida Kater, Marcelo Costa Batista, Sandra Roberta Gouvea Ferreira, Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe, Metabolism, 2010, 59, 6, 921

    CrossRef

  29. 29
    Rubina A. Karatela, Gurmukh S. Sainani, Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease, Atherosclerosis, 2010, 209, 1, 235

    CrossRef

  30. 30
    Laurence Hoareau, Régis Roche, Palmitoylethanolamide, adipocytes and obesity-related inflammatory states, Drug Discovery Today: Disease Mechanisms, 2010, 7, 3-4, e205

    CrossRef

  31. 31
    T. MEAS, S. DEGHMOUN, D. CHEVENNE, B. GABORIT, M.-C. ALESSI, C. LÉVY-MARCHAL, Plasminogen activator inhibitor type-1 is an independent marker of metabolic disorders in young adults born small for gestational age, Journal of Thrombosis and Haemostasis, 2010, 8, 12
  32. 32
    Matteo Cesari, Marco Pahor, Raffaele Antonelli Incalzi, REVIEW: Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions, Cardiovascular Therapeutics, 2010, 28, 5
  33. 33
    Katrien HJ Gaens, Coen DA Stehouwer, Casper G Schalkwijk, The Nε-(carboxymethyl)lysine–RAGE axis: putative implications for the pathogenesis of obesity-related complications, Expert Review of Endocrinology & Metabolism, 2010, 5, 6, 839

    CrossRef

  34. 34
    G. Plehn, T.W. Jax, M. Leschke, A. Meissner, H.-J. Trappe, Altersabhängige Veränderungen des hämostaseologischen Risikoprofils aus kardiologischer Sicht, Der Kardiologe, 2009, 3, 6, 480

    CrossRef

  35. 35
    Khalid Alwaili, Khalid Alrasadi, Zuhier Awan, Jacques Genest, Approach to the diagnosis and management of lipoprotein disorders, Current Opinion in Endocrinology, Diabetes and Obesity, 2009, 16, 2, 132

    CrossRef

  36. 36
    Kenichi A. Tanaka, Nigel S. Key, Jerrold H. Levy, Blood Coagulation: Hemostasis and Thrombin Regulation, Anesthesia & Analgesia, 2009, 108, 5, 1433

    CrossRef

  37. 37
    G. Fanciulli, A. Delitala, G. Delitala, Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone, Human Reproduction Update, 2009, 15, 3, 341

    CrossRef

  38. 38
    B. Singh, S. Arora, B. Goswami, V. Mallika, Metabolic syndrome: A review of emerging markers and management, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2009, 3, 4, 240

    CrossRef

  39. 39
    Paul D. Stein, Jose Goldman, Obesity and Thromboembolic Disease, Clinics in Chest Medicine, 2009, 30, 3, 489

    CrossRef

  40. 40
    Yin-Yi Chou, Wayne H-H Sheu, Yih-Jing Tang, Yi-Ming Chen, Szu-Chia Liao, Ya-Wen Chuang, Chu-Sheng Lin, Der-Yuan Chen, Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan, Archives of Gerontology and Geriatrics, 2009, 49, S41

    CrossRef

  41. 41
    Shiny Mathewkutty, Darren K McGuire, Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment, Expert Review of Cardiovascular Therapy, 2009, 7, 5, 541

    CrossRef

  42. 42
    Chin Wing Ko, Zhenquan Wei, Richard J. Marsh, Daven A. Armoogum, Nick Nicolaou, Angus J. Bain, Aiwu Zhou, Liming Ying, Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy, Molecular BioSystems, 2009, 5, 9, 1025

    CrossRef

  43. 43
    Antonio Barbato, Roberto Iacone, Giovanni Tarantino, Ornella Russo, Paolo Sorrentino, Sonia Avallone, Ferruccio Galletti, Eduardo Farinaro, Elisabetta Della Valle, Pasquale Strazzullo, Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy, Internal and Emergency Medicine, 2009, 4, 4, 315

    CrossRef

  44. 44
    J. Tordjman, M. Guerre-Millo, K. Clément, Adipose tissue inflammation and liver pathology in human obesity, Diabetes & Metabolism, 2008, 34, 6, 658

    CrossRef

  45. 45
    Yan Li Cao, Cui Zhu Hu, Xin Meng, Di Fei Wang, Jin Zhang, Expression of TNF-α protein in omental and subcutaneous adipose tissue in obesity, Diabetes Research and Clinical Practice, 2008, 79, 2, 214

    CrossRef

  46. 46
    Yun-Hee Noh, Se-Myung Lee, Eun-Ju Kim, Do-Young Kim, Hyunil Lee, Jun-Ho Lee, Ju-Han Lee, So-Young Park, Ja-Hyun Koo, Jun-Ho Wang, In-Ja Lim, Soo-Bong Choi, Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion, Diabetes/Metabolism Research and Reviews, 2008, 24, 5
  47. 47
    Mizuho OKAZAKI, Yasumasa IWASAKI, He JING, Mitsuru NISHIYAMA, Takafumi TAGUCHI, Makoto TSUGITA, Yoshinori TANIGUCHI, Machiko KAMBAYASHI, Kozo HASHIMOTO, Insulin Enhancement of Cytokine-Induced Coagulation/Inflammation-Related Gene Transcription in Hepatocytes, Endocrine Journal, 2008, 55, 6, 967

    CrossRef

  48. 48
    A. Ågren, B. Wiman, S. Schulman, Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index, Journal of Internal Medicine, 2008, 264, 6
  49. 49
    Christopher P. Cannon, Mixed Dyslipidemia, Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease: Clinical Implications, The American Journal of Cardiology, 2008, 102, 12, 5L

    CrossRef

  50. 50
    Marlien Pieters, Hester H. Vorster, Nutrition and hemostasis: A focus on urbanization in South Africa, Molecular Nutrition & Food Research, 2008, 52, 1
  51. 51
    Koji YAMAMOTO, PAI-1 and lifestyle-related illnesses, Japanese Journal of Thrombosis and Hemostasis, 2008, 19, 1, 55

    CrossRef

  52. 52
    Carlos Zamarrón, Jorge Ricoy, Alberto Riveiro, Francisco Gude, Plasminogen Activator Inhibitor-1 in Obstructive Sleep Apnea Patients with and without Hypertension, Lung, 2008, 186, 3, 151

    CrossRef

  53. 53
    Reza Alizadeh Dehnavi, Edith D. Beishuizen, Marcel A. van de Ree, Saskia Le Cessie, Menno V. Huisman, Cornelis Kluft, Hans M.G. Princen, Jouke T. Tamsma, The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus, European Journal of Internal Medicine, 2008, 19, 2, 115

    CrossRef

  54. 54
    I. Juhan-Vague, M.-C. Alessi, Tissu adipeux viscéral et thrombose, Archives des Maladies du Coeur et des Vaisseaux - Pratique, 2008, 2008, 167, 19

    CrossRef

  55. 55
    S. G. Wannamethee, N. Sattar, A. Rumley, P. H. Whincup, L. Lennon, G. D.O. Lowe, Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men, Diabetes Care, 2008, 31, 5, 995

    CrossRef

  56. 56
    Sercin Karahuseyinoglu, Ozgur Cinar, Emine Kilic, Fadil Kara, Guvem Gumus Akay, Duygu Özel Demiralp, Ajlan Tukun, Duygu Uckan, Alp Can, Biology of Stem Cells in Human Umbilical Cord Stroma: In Situ and In Vitro Surveys, STEM CELLS, 2007, 25, 2
  57. 57
    Fahumiya Samad, Contribution of sphingolipids to the pathogenesis of obesity, Future Lipidology, 2007, 2, 6, 625

    CrossRef

  58. 58
    Rie Sasaki, Natsumi Nishimura, Hiromi Hoshino, Yasuka Isa, Maho Kadowaki, Takahito Ichi, Akihito Tanaka, Shin Nishiumi, Itsuko Fukuda, Hitoshi Ashida, Fumihiko Horio, Takanori Tsuda, Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice, Biochemical Pharmacology, 2007, 74, 11, 1619

    CrossRef

  59. 59
    A. K. M. Tarikuz Zaman, Satoshi Fujii, David J. Schneider, Douglas J. Taatjes, H. Roger Lijnen, Burton E. Sobel, Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants, Histochemistry and Cell Biology, 2007, 128, 2, 135

    CrossRef

  60. 60
    A. Greyling, M. Pieters, T. Hoekstra, W. Oosthuizen, A.E. Schutte, Differences in the association of PAI-1 activity with the metabolic syndrome between African and Caucasian women, Nutrition, Metabolism and Cardiovascular Diseases, 2007, 17, 7, 499

    CrossRef

  61. 61
    Roland von Känel, José S. Loredo, Sonia Ancoli-Israel, Paul J. Mills, Joel E. Dimsdale, Elevated plasminogen activator inhibitor 1 in sleep apnea and its relation to the metabolic syndrome: an investigation in 2 different study samples, Metabolism, 2007, 56, 7, 969

    CrossRef

  62. 62
    Mojca Stegnar, Tjaša Vižintin Cuderman, Mojca Božič, Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability, Clinical Chemical Laboratory Medicine, 2007, 45, 1

    CrossRef

  63. 63
    Silvia I Anghel, Walter Wahli, Fat poetry: a kingdom for PPARγ, Cell Research, 2007, 17, 6, 486

    CrossRef

  64. 64
    Katherine Esposito, Miryam Ciotola, Dario Giugliano, Mediterranean diet and the metabolic syndrome, Molecular Nutrition & Food Research, 2007, 51, 10
  65. 65
    S. S. Nerurkar, A. R. Olzinski, K. S. Frazier, R. C. Mirabile, S. P. O'Brien, J. Jing, D. Rajagopalan, T.-L. Yue, R. N. Willette, p38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1, Biomarkers, 2007, 12, 1, 87

    CrossRef

  66. 66
    S. Goya Wannamethee, Julia Tchernova, Peter Whincup, Gordon D.O. Lowe, Anne Kelly, Ann Rumley, A. Michael Wallace, Naveed Sattar, Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease, Atherosclerosis, 2007, 191, 2, 418

    CrossRef

  67. 67
    S. Yener, M. Akarsu, T. Demir, B. Akinci, O. Sagol, F. Bayraktar, M. A. Ozcan, E. Tankurt, S. Yesil, Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis, Journal of Endocrinological Investigation, 2007, 30, 10, 810

    CrossRef

  68. 68
    Jiyun Ahn, Hyunjung Lee, Suna Kim, Taeyoul Ha, Resveratrol inhibits TNF-α-induced changes of adipokines in 3T3-L1 adipocytes, Biochemical and Biophysical Research Communications, 2007, 364, 4, 972

    CrossRef

  69. 69
    S. EI AYACHI, O. PAULMYER-LACROIX, M. VERDIER, M.-C. ALESSI, A. DUTOUR, M. GRINO, 11β-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women, Journal of Thrombosis and Haemostasis, 2006, 4, 3
  70. 70
    Barbara Salobir, Miso Sabovic, A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism, Blood Coagulation & Fibrinolysis, 2006, 17, 7, 551

    CrossRef

  71. 71
    F. Samad, K. D. Hester, G. Yang, Y. A. Hannun, J. Bielawski, Altered Adipose and Plasma Sphingolipid Metabolism in Obesity: A Potential Mechanism for Cardiovascular and Metabolic Risk, Diabetes, 2006, 55, 9, 2579

    CrossRef

  72. 72
    A.-M. Aas, I. Seljeflot, P. A. Torjesen, L. M. Diep, P. M. Thorsby, K. I. Birkeland, Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes, Diabetologia, 2006, 49, 5, 872

    CrossRef

  73. 73
    Jeong Ai Kim, Nam D Tran, Zhen Li, Fan Yang, Weilin Zhou, Mark J Fisher, Brain endothelial hemostasis regulation by pericytes, Journal of Cerebral Blood Flow & Metabolism, 2006, 26, 2, 209

    CrossRef

  74. 74
    B Goichot, L Grunebaum, D Desprez, S Vinzio, L Meyer, JL Schlienger, M Lessard, C Simon, Circulating procoagulant microparticles in obesity, Diabetes & Metabolism, 2006, 32, 1, 82

    CrossRef

  75. 75
    M. CLAESSON, L. S. BIRGANDER, J.-H. JANSSON, B. LINDAHL, G. BURELL, K. ASPLUND, C. MATTSSON, Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial, Journal of Internal Medicine, 2006, 260, 4
  76. 76
    Yoshimasa Aso, Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor, Future Lipidology, 2006, 1, 4, 429

    CrossRef

  77. 77
    C. Dieterle, R. Landgraf, Folgeerkrankungen und Komplikationen der Adipositas, Der Internist, 2006, 47, 2, 141

    CrossRef

  78. 78
    Massimo Franchini, Hemostasis and aging, Critical Reviews in Oncology/Hematology, 2006, 60, 2, 144

    CrossRef

  79. 79
    Rosario Martos, Miguel Valle, Rosario Morales, Ramón Cañete, M. Inmaculada Gavilan, Víctor Sánchez-Margalet, Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children, Metabolism, 2006, 55, 1, 72

    CrossRef

  80. 80
    Rexford S. Ahima, Metabolic Actions of Adipocyte Hormones: Focus on Adiponectin, Obesity, 2006, 14, S2
  81. 81
    Ambika Babu, Leon Fogelfeld, Metabolic Syndrome and Prediabetes, Disease-a-Month, 2006, 52, 2-3, 55

    CrossRef

  82. 82
    Takanori Tsuda, Yuki Ueno, Toshikazu Yoshikawa, Hitoshi Kojo, Toshihiko Osawa, Microarray profiling of gene expression in human adipocytes in response to anthocyanins, Biochemical Pharmacology, 2006, 71, 8, 1184

    CrossRef

  83. 83
    M. CANONICO, E. OGER, J. CONARD, G. MEYER, H. LÉVESQUE, N. TRILLOT, M. T. BARRELLIER, D. WAHL, J. EMMERICH, P. Y. SCARABIN, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study, Journal of Thrombosis and Haemostasis, 2006, 4, 6
  84. 84
    S. E. Kahn, B. Zinman, S. M. Haffner, M. C. O'Neill, B. G. Kravitz, D. Yu, M. I. Freed, W. H. Herman, R. R. Holman, N. P. Jones, J. M. Lachin, G. C. Viberti, Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes, Diabetes, 2006, 55, 8, 2357

    CrossRef

  85. 85
    H Erdem, A Dinc, S Pay, I Simsek, M Turan, Peripheral insulin resistance in patients with Behçet's disease, Journal of the European Academy of Dermatology and Venereology, 2006, 20, 4
  86. 86
    M. Berberoǧlu, O. Evliyaoǧlu, P. Adıyaman, G. Öcal, Β. Ulukol, F. Şimşek, Ζ. Şıklar, Α. Törel, D. Özel, N. Akar, Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children, Journal of Pediatric Endocrinology and Metabolism, 2006, 19, 5

    CrossRef

  87. 87
    H.R. Lijnen, Saquinavir does not affect adipose tissue development or metabolic parameters in mice on high fat diet, Thrombosis Research, 2006, 118, 4, 539

    CrossRef

  88. 88
    Paresh Dandona, Husam Ghanim, Priya Mohanty, Ajay Chaudhuri, The metabolic syndrome: linking oxidative stress and inflammation to obesity, type 2 diabetes, and the syndrome, Drug Development Research, 2006, 67, 7
  89. 89
    Z. T. Bloomgarden, Third Annual World Congress on the Insulin Resistance Syndrome: Atherothrombotic disease, Diabetes Care, 2006, 29, 8, 1973

    CrossRef

  90. 90
    Margaret A. Allman-Farinelli, Kerry Gomes, Emmanuel J. Favaloro, Peter Petocz, A Diet Rich in High-Oleic-Acid Sunflower Oil Favorably Alters Low-Density Lipoprotein Cholesterol, Triglycerides, and Factor VII Coagulant Activity, Journal of the American Dietetic Association, 2005, 105, 7, 1071

    CrossRef

  91. 91
    Susan J. Appel, Natalie A. Floyd, Joyce Newman Giger, Michael T. Weaver, Huabin Luo, Tiffany Hannah, Fernando Ovalle, African American Women, Metabolic Syndrome, and National Cholesterol Education Program Criteria, Nursing Research, 2005, 54, 5, 339

    CrossRef

  92. 92
    Giuseppe Derosa, Antonio V. Gaddi, Mario N. Piccinni, Leonardina Ciccarelli, Sibilla Salvadeo, Emmanouil Peros, Morena Ghelfi, Ilaria Ferrari, Arrigo F. G. Cicero, Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005, 25, 5
  93. You have free access to this content93
    Susan J. Appel, Joanne S. Harrell, Marsha L. Davenport, Central Obesity, the Metabolic Syndrome, and Plasminogen Activator Inhibitor-1 in Young Adults, Journal of the American Academy of Nurse Practitioners, 2005, 17, 12
  94. 94
    G. D. O. LOWE, Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease, Journal of Thrombosis and Haemostasis, 2005, 3, 8
  95. 95
    Mark F. McCarty, De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome, Medical Hypotheses, 2005, 64, 2, 388

    CrossRef

  96. 96
    A. BLANN, Hemostatic abnormalities associated with obesity and the metabolic syndrome, Journal of Thrombosis and Haemostasis, 2005, 3, 5
  97. 97
    G. D. O. LOWE, A. RUMLEY, S. G. WANNAMETHEE, Hemostatic abnormalities associated with obesity and the metabolic syndrome, Journal of Thrombosis and Haemostasis, 2005, 3, 5
  98. 98
    I. JUHAN-VAGUE, M. C. ALESSI, Hemostatic abnormalities associated with obesity and the metabolic syndrome, Journal of Thrombosis and Haemostasis, 2005, 3, 5
  99. 99
    James Shepherd, John Betteridge, Luc Van Gaal, Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel, Current Medical Research and Opinion, 2005, 21, 5, 665

    CrossRef

  100. 100
    K. YAMAMOTO, T. KOJIMA, T. ADACHI, M. HAYASHI, T. MATSUSHITA, J. TAKAMATSU, D. J. LOSKUTOFF, H. SAITO, Obesity enhances the induction of plasminogen activator inhibitor-1 by restraint stress: a possible mechanism of stress-induced renal fibrin deposition in obese mice, Journal of Thrombosis and Haemostasis, 2005, 3, 7
  101. 101
    P. W. M. Hermans, J. A. Hazelzet, Plasminogen Activator Inhibitor Type 1 Gene Polymorphism and Sepsis, Clinical Infectious Diseases, 2005, 41, Supplement 7, S453

    CrossRef

  102. 102
    Mi??o ??abovi??, Toma?? Klju??ev??ek, Resolution of Budd???Chiari syndrome due to activation of endogenous fibrinolysis that may be induced by weight reduction, Blood Coagulation & Fibrinolysis, 2005, 16, 1, 51

    CrossRef

  103. 103
    Anne Bouloumié, Cyrile Anne Curat, Coralie Sengenès, Karine Lolmède, Alexandra Miranville, Rudi Busse, Role of macrophage tissue infiltration in metabolic diseases, Current Opinion in Clinical Nutrition and Metabolic Care, 2005, 8, 4, 347

    CrossRef

  104. 104
    Zhe Zhou, Yong Liu, Ai-Dong Miao, Sheng-Qi Wang, Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-α treated human umbilical vein endothelial cells, Journal of Cellular Biochemistry, 2005, 96, 1
  105. 105
    Baihua Hu, James W. Jetter, Jay E. Wrobel, Thomas M. Antrilli, Jean S. Bauer, Li Di, Sergiusz Polakowski, Uday Jain, David L. Crandall, Synthesis and SAR of 2-carboxylic acid indoles as inhibitors of plasminogen activator inhibitor-1, Bioorganic & Medicinal Chemistry Letters, 2005, 15, 15, 3514

    CrossRef

  106. 106
    Malaka B Jackson, Suzette Y Osei, Rexford S Ahima, The endocrine role of adipose tissue: focus on adiponectin and resistin, Current Opinion in Endocrinology & Diabetes, 2005, 12, 2, 163

    CrossRef

  107. 107
    S. Goya Wannamethee, Gordon D.O. Lowe, A. Gerald Shaper, Ann Rumley, Lucy Lennon, Peter H. Whincup, The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men, Atherosclerosis, 2005, 181, 1, 101

    CrossRef

  108. 108
    J.T. Tamsma, I.M. Jazet, E.D. Beishuizen, A.J. Fogteloo, A.E. Meinders, M.V. Huisman, The metabolic syndrome: A vascular perspective, European Journal of Internal Medicine, 2005, 16, 5, 314

    CrossRef

  109. 109
    Dusanka Obradovic, Thrombophilia and thrombosis, Medicinski pregled, 2005, 58, 7-8, 368

    CrossRef

  110. 110
    E. Simeoni, M. M. Hoffmann, B. R. Winkelmann, J. Ruiz, S. Fleury, B. O. Boehm, W. M�rz, G. Vassalli, Association between the A?2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus, Diabetologia, 2004, 47, 9, 1574

    CrossRef

  111. 111
    Susan J. Appel, Joyce Newman Giger, Natalie A. Floyd, Dysmetabolic Syndrom, The Nurse Practitioner, 2004, 29, 10, 18

    CrossRef

  112. 112
    H. S. Lim, G. Y. H. Lip, Impaired fasting glycaemia vs. impaired glucose tolerance: two sides of the same coin with implications for cardiovascular risk, Diabetic Medicine, 2004, 21, 4
  113. 113
    Frans J Maritz, Insulin resistance and vascular disease, Journal of Endocrinology, Metabolism and Diabetes of South Africa, 2004, 9, 2, 54

    CrossRef

  114. 114
    Anton J. G. Horrevoets, Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance, British Journal of Haematology, 2004, 125, 1
  115. 115
    Gabriela De Larrañaga, Silvia Perés, Jorge Benetucci, Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy, Hepatology, 2004, 40, 6
  116. 116
    Scott M Grundy, What is the contribution of obesity to the metabolic syndrome?, Endocrinology and Metabolism Clinics of North America, 2004, 33, 2, 267

    CrossRef

  117. 117
    Marie-Christine Alessi, H. Roger Lijnen, Delphine Bastelica, Irene Juhan-Vague, Adipose Tissue and Atherothrombosis, Pathophysiology of Haemostasis and Thrombosis, 2003, 33, 5-6, 290

    CrossRef

  118. 118
    Karine Clément, Adipokines, Inflammation, and Obesity,
  119. 119
    Yoogoo Kang, Elia Elia, Current view of coagulation system,
  120. 120
    Terence K. Trow, Richard A. Matthay, Management of Venous Thromboembolism in the Critically Ill Obese Patient,